Table 3.
CMR Findings
| CMR data | Whole Cohort (N = 52) | Conduction Abnormality Positive (N = 31) | Conduction Abnormality Negative (N = 21) | P value |
|---|---|---|---|---|
| LVEF (%) | 60 ± 6 | 59 ± 6 | 60 ± 6 | 0.687 |
| LV EDVI, ml/m2 | 65 ± 15 | 65 ± 14 | 66 ± 15 | 0.728 |
| LV ESVI, ml/m2 | 26 ± 8 | 26 ± 8 | 26 ± 7 | 0.940 |
| LV mass index, g/m2 | 44 ± 11 | 45 ± 14 | 43 ± 6 | 0.563 |
| LAVI, ml/m2 | 30 ± 11 | 31 ± 10 | 29 ± 12 | 0.634 |
| LGE, N (%) | 22 (42%) | 13 (42) | 9 (43) | 0.999 |
| LGE mass, g | 2.4 ± 3.6 | 2.4 ± 3.8 | 2.3 ± 3.4 | 0.876 |
| LGE, % | 3.1 ± 4.6 | 3.0 ± 4.6 | 3.1 ± 4.7 | 0.975 |
| ECV, % | 25 ± 3 | 26 ± 3 | 24 ± 3 | 0.050 |
Data are presented as mean ± SD or N (%). LVEF left ventricular ejection fraction, EDVI end-diastolic volume index, ESVI end-systolic volume index, LAVI left atrial volume index, LGE late gadolinium enhancement, ECV extracellular volume